{"text": ["How", "Did", "Novartis\u2019s", "Gleevec,", "Tasigna,", "and", "Sandostatin", "Perform", "in", "4Q17?"], "created_at": "2018-03-28 21:00:03"}
{"text": ["How", "Did", "Novartis\u2019s", "Gleevec,", "Tasigna,", "and", "Sandostatin", "Perform", "in", "4Q17?"], "created_at": "2018-03-28 21:00:03"}
{"text": ["How", "Novartis\u2019s", "Oncology", "Segment", "Drugs", "Are", "Performing"], "created_at": "2018-03-28 17:59:50"}
{"text": ["How", "Did", "Novartis", "Perform", "in", "4Q17", "and", "Full-Year", "2017?"], "created_at": "2018-03-28 17:59:43"}
{"text": ["Company", "News", "For", "Mar", "28,", "2018"], "created_at": "2018-03-28 16:08:38"}
{"text": ["Company", "News", "For", "Mar", "28,", "2018"], "created_at": "2018-03-28 16:08:38"}
{"text": ["European", "ADRs", "Move", "Higher", "in", "Wednesday", "Trading"], "created_at": "2018-03-28 15:42:17"}
{"text": ["European", "ADRs", "Move", "Higher", "in", "Wednesday", "Trading"], "created_at": "2018-03-28 15:42:17"}
{"text": ["Glaxo", "(GSK)", "Buys", "Novartis'", "Stake", "in", "Consumer", "Healthcare", "JV"], "created_at": "2018-03-28 15:07:13"}
{"text": ["Glaxo", "(GSK)", "Buys", "Novartis'", "Stake", "in", "Consumer", "Healthcare", "JV"], "created_at": "2018-03-28 15:07:13"}
{"text": ["Company", "News", "For", "Mar", "28,", "2018"], "created_at": "2018-03-28 14:18:02"}
{"text": ["Health", "care", "trumps", "terrorism,", "gun", "violence", "concerns", "for", "Americans"], "created_at": "2018-03-28 14:13:00"}
{"text": ["In", "Battle", "To", "Cut", "Drug", "Prices,", "Outcome-Based", "Pricing", "Carries", "Big", "Risks", "For", "Biopharma"], "created_at": "2018-03-28 13:19:00"}
{"text": ["Glaxo", "(GSK)", "Buys", "Novartis&apos;", "Stake", "in", "Consumer", "Healthcare", "JV"], "created_at": "2018-03-28 13:12:01"}
{"text": ["The", "Swiss", "Stock", "Market", "Jumped", "On", "Strength", "Of", "Defensive", "Heavyweights"], "created_at": "2018-03-28 12:20:00"}
{"text": ["The", "Swiss", "Stock", "Market", "Jumped", "On", "Strength", "Of", "Defensive", "Heavyweights"], "created_at": "2018-03-28 12:20:00"}
{"text": ["Novartis", "AG", "--", "Moody's:", "Novartis's", "sale", "of", "joint", "venture", "stake", "could", "be", "credit", "positive,", "but", "uncertainty", "around", "use", "of", "proceeds", "and", "financial", "policies", "persist"], "created_at": "2018-03-28 12:01:08"}
{"text": ["Biotech", "Stocks", "Facing", "FDA", "Decision", "In", "April"], "created_at": "2018-03-28 07:58:00"}
{"text": ["Biotech", "Stocks", "Facing", "FDA", "Decision", "In", "April"], "created_at": "2018-03-28 07:58:00"}
{"text": ["[$$]", "GSK", "Buys", "Novartis\u2019s", "Stake", "in", "Health-Care", "Unit", "for", "$13", "Billion"], "created_at": "2018-03-28 04:34:30"}
{"text": ["[$$]", "Inside", "story", "about", "the", "past", "few", "weeks", "of", "dealmaking", "at", "GSK"], "created_at": "2018-03-28 04:05:10"}
